Added to YB: 2023-05-29
Pitch date: 2023-05-29
RXDX [bullish]
Prometheus Biosciences, Inc.
+0.65%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Prometheus Biosciences, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of novel therapeutics for the treatment of inflammatory bowel diseases (IBD).
Market Cap
$9.6B
Pitch Price
$198.62
Price Target
N/A
Dividend
N/A
EV/EBITDA
-56.41
P/E
-56.74
EV/Sales
2.2K
Sector
Biotechnology
Category
N/A
Show full summary:
PROMETHEUS BIOSCNC INC RXDX
A summary for this pitch has not been created yet.
Read full article (0 min)